Nymphaea pubescens Willd. extract and its flavonoid constituents vasodilate rat isolated pulmonary artery via NO-sGC-cGMP pathway
Background: Pulmonary arterial hypertension (PAH) is a progressive disorder indicated by elevated blood pressure in pulmonary artery (PA). PAH treatment focuses on inducing PA vasodilation by inhibiting phosphodiesterase 5 (PDE5), the enzyme prominently expressed in pulmonary vasculature. Our previo...
Saved in:
Main Authors: | Teerapap Panklai, Prapapan Temkitthawon, Nungruthai Suphrom, Corine Girard, Perle Totoson, Kowit Hengphasatporn, Yasuteru Shigeta, Krongkarn Chootip, Kornkanok Ingkaninan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Phytomedicine Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667031325000065 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency
by: Mark A. Colantonio, et al.
Published: (2025-01-01) -
Successful Endovascular Management of Recurrent Hemoptysis due to Multiple Rasmussen Aneurysms in a Case of Pulmonary Tuberculosis: A Rare Case Scenario
by: Shritik Devkota, et al.
Published: (2024-06-01) -
Arduous management in treatment of elderly patient with pulmonary arterial hypertension and cardiopulmonary comorbidities
by: Yu Enomoto, et al.
Published: (2025-01-01) -
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
by: Richard Channick, MD, et al.
Published: (2025-02-01) -
Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH)
by: Markku Pentikäinen, et al.
Published: (2025-02-01)